Naghmeh Radhakrishna

Melbourne, VIC, Australia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 27 publications

Mepolizumab treatment and reduced oral corticosteroid exposure improves symptoms of depression and anxiety in severe eosinophilic asthma: data from the Australian Mepolizumab Registry.

Mepolizumab treatment and reduced oral corticosteroid exposure improves symptoms of depression and anxiety in severe eosinophilic asthma: data from the Australian Mepolizumab Registry.

Journal: Respiratory medicine

Published: May 30, 2025

Biologics (mepolizumab and omalizumab) induced remission in severe asthma patients.

Biologics (mepolizumab and omalizumab) induced remission in severe asthma patients.

Journal: Allergy

Published: April 02, 2023

Trait profiles in difficult-to-treat asthma: Clinical impact and response to systematic assessment.

Trait profiles in difficult-to-treat asthma: Clinical impact and response to systematic assessment.

Journal: Allergy

Published: September 27, 2022

Comorbidities Modify the Phenotype but Not the Treatment Effectiveness to Mepolizumab in Severe Eosinophilic Asthma.

Comorbidities Modify the Phenotype but Not the Treatment Effectiveness to Mepolizumab in Severe Eosinophilic Asthma.

Journal: The journal of allergy and clinical immunology. In practice

Published: February 15, 2022

Thunderstorm asthma in seasonal allergic rhinitis: The TAISAR study.

Thunderstorm asthma in seasonal allergic rhinitis: The TAISAR study.

Journal: The Journal of allergy and clinical immunology

Published: March 29, 2021

Mepolizumab and Oral Corticosteroid Stewardship: Data from the Australian Mepolizumab Registry.

Mepolizumab and Oral Corticosteroid Stewardship: Data from the Australian Mepolizumab Registry.

Journal: The journal of allergy and clinical immunology. In practice

Published: October 08, 2020

Work-related asthma: A position paper from the Thoracic Society of Australia and New Zealand and the National Asthma Council Australia.

Work-related asthma: A position paper from the Thoracic Society of Australia and New Zealand and the National Asthma Council Australia.

Journal: Respirology (Carlton, Vic.)

Published: June 14, 2020

Mepolizumab effectiveness and identification of super-responders in severe asthma.

Mepolizumab effectiveness and identification of super-responders in severe asthma.

Journal: The European respiratory journal

Published: December 17, 2019

Paradoxical Vocal Fold Motion in Difficult Asthma Is Associated with Dysfunctional Breathing and Preserved Lung Function.

Paradoxical Vocal Fold Motion in Difficult Asthma Is Associated with Dysfunctional Breathing and Preserved Lung Function.

Journal: The journal of allergy and clinical immunology. In practice

Published: September 19, 2019

Systematic Assessment for Difficult and Severe Asthma Improves Outcomes and Halves Oral Corticosteroid Burden Independent of Monoclonal Biologic Use.

Systematic Assessment for Difficult and Severe Asthma Improves Outcomes and Halves Oral Corticosteroid Burden Independent of Monoclonal Biologic Use.

Journal: The journal of allergy and clinical immunology. In practice

Published: September 14, 2019

Continued loss of asthma control following epidemic thunderstorm asthma.

Continued loss of asthma control following epidemic thunderstorm asthma.

Journal: Asia Pacific allergy

Published: September 09, 2019

Severe Asthma Global Evaluation (SAGE): An Electronic Platform for Severe Asthma.

Severe Asthma Global Evaluation (SAGE): An Electronic Platform for Severe Asthma.

Journal: The journal of allergy and clinical immunology. In practice

Published: December 16, 2018

Showing 1-12 of 27

Last Updated: 09/26/2026